Lactulose Aiwa Pflaumenaroma T&d Pharma

Lactulose, the active ingredient in Lactulose Aiwa Pflaumenaroma T&d Pharma, is an osmotic laxative presented as an oral solution for oral use. It is employed to relieve chronic constipation and to lower blood ammonia levels in patients with hepatic encephalopathy, improving bowel regularity and neurological status.

GNH USA supplies Lactulose Aiwa Pflaumenaroma T&d Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Lactulose is an osmotic laxative used to manage conditions related to impaired bowel motility and hepatic ammonia accumulation. - Constipation: relieves chronic constipation by increasing colonic water content and softening stools, promoting regular bowel movements. - Hepatic encephalopathy: lowers blood ammonia concentrations, helping improve mental status in patients with liver disease. - Opioid‑induced constipation: counteracts opioid‑related reduced gut motility, providing symptomatic relief in patients receiving chronic opioid therapy.

Lactulose may cause a range of adverse reactions, varying from mild to serious. Common Side Effects: - Abdominal cramping: mild to moderate discomfort. - Flatulence: increased intestinal gas. - Diarrhea: loose stools, especially at higher doses. Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical care. - Significant electrolyte disturbances: marked hypokalemia or hyponatremia. - Allergic reaction: rash, urticaria, or angioedema.

When prescribing lactulose, several precautions should be considered to ensure safe and effective use. - Renal function: assess kidney status, as impaired clearance may affect fluid balance. - Electrolyte monitoring: check serum potassium and sodium, especially in long‑term therapy. - Diabetes mellitus: lactulose contains sugars; monitor blood glucose in diabetic patients. - Galactosemia: avoid use in patients with this inherited disorder. - Hepatic impairment: adjust dose and monitor ammonia levels in severe liver disease. - Store at ambient temperature: keep the solution in its original container, protect from moisture and direct sunlight.

Lactulose can interact with other medicines, influencing efficacy or safety. Major Interactions (Avoid): - Antacids: may reduce the osmotic effect of lactulose, decreasing its efficacy. - Diuretics: combined use can increase the risk of electrolyte imbalance and dehydration. - Broad‑spectrum antibiotics: may alter colonic flora, diminishing lactulose metabolism. Moderate Interactions (Monitor Closely): - Probiotics: may enhance laxative effect, leading to increased stool frequency. - Other laxatives: additive effect may cause diarrhea or electrolyte loss. - Oral iron supplements: may increase gastrointestinal irritation when taken together.